Cinacalcet HCl (Sensipar/ Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism - Concepedia

Concepedia

Publication | Closed Access

Cinacalcet HCl (Sensipar/ Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism

50

Citations

0

References

2007

Year

J. Reid Sterrett, Hans Krister Stummvoll, Udo Bahner, A. P. S. Disney, Stephen Soroka, Cindy L Corpier, J.A. Arruda, L. E. Schwanauer, Preston Klassen, Kurt Olson,

Clinical Nephrology

Abstract

Treatment with cinacalcet is a safe and effective therapy for long-term control of secondary hyperparathyroidism. 1-year therapy with cinacalcet was associated with sustained, clinically significant reductions in calcium, Ca x P and iPTH which allowed a greater percentage of patients to achieve NKF-KDOQI target goals for PTH and Ca x P.